This reports provides a data-driven overview of the current and future competitive landscape in AV therapeutics.
GlobalData epidemiologists estimated more than 403 million diagnosed prevalent cases of AV in 2023 in the 16 countries covered in GlobalData’s epidemiology forecast for AV.
Topical retinoids and topical antibiotics are usually the first-line therapy for mild-to-moderate acne.
The R&D activity is moderate within the AV space, with total 13 molecules present in the late-stage pipeline.
The US is emerging as the key country for conducting AV trials.
Acquisition was the most prevalent deal type in North America, Asia-Pacific, and Europe.
Scope
GlobalData’s AV: Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include -
Disease Landscape
Disease Overview
Epidemiology Overview
Treatment Overview
Marketed Products Assessment
Breakdown by Mechanism of Action, Route of Administration
Product Profiles with Sales Forecast
Pricing and Reimbursement Assessment
Annual Therapy Cost
Time to Pricing and Time to Reimbursement
Pipeline Assessment
Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
Product Profiles with Sales Forecast
Late-to-mid-stage Pipeline Drugs
Phase Transition Success Rate and Likelihood of Approval
Clinical Trials Assessment
Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
Enrolment Analytics, Site Analytics, Feasibility Analysis
Deals Landscape
Mergers, Acquisitions, and Strategic Alliances by Region
Overview of Recent Deals
Commercial Assessment
Key Market Players
Future Market Catalysts
Reasons to Buy
Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the AV market.
Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global AV market in the future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Report Scope
Abbreviations
Key Findings
Disease Overview
Disease Etiology
Epidemiology Overview
Epidemiology Overview - Diagnosed Prevalent Cases of AV in 2023 and 2026